Stocks
Pfizer (PFE) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.14 | 1.85 | 0.21 | 0.28 | 5.92 | 5.28 | |||
| Changes by years, y/y, % | +105% | -14% | -89% | +34% | +2 030% | +41.4% | |||
Pfizer. Debt/EBITDA
Pfizer. Debt/EBITDA, changes, %
Pfizer (PFE) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 5.63 | -11.4 | 809.8 | -2.03 | 9.15 | 5.28 | ||
| Changes by years, y/y, % | +1 185% | +28 621% | +50 348% | -200% | +352% | |||
| Changes by quarters, q/q, % | +178% | -302% | -7 211% | -100% | -551% | |||
